Will Jnj Beat Earnings

October 26, 2020 Post a Comment

JNJ beat EPS estimates by a solid 022 and the company smashed revenue targets by 927 million. Johnson Johnson NYSEJNJ Earnings Information Johnson Johnson last announced its quarterly earnings results on January 25th 2021.

Why Penn Virginia Pvac Could Beat Earnings Estimates Again Nasdaq

The firm earned 2250 million during the quarter compared to analyst estimates of 2162 billion.

Will jnj beat earnings. Johnson Johnson appears a compelling earnings-beat candidate. Johnson Johnson on Tuesday reported third-quarter earnings and revenue that beat Wall Streets expectations led by higher sales in its medical-device unit and higher demand for some of its. Shares are down 79 since reporting last quarter.

However investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings. The reported 186 EPS for the quarter beating analysts consensus estimates of 182 by 004. For the last reported quarter it was expected that Johnson Johnson would post earnings of 203 per share when it actually produced earnings of 230 delivering a surprise of 1330.

The company has such a diversified revenue base in pharmaceuticals and medical devices that gains in. January 26 2021 1010 AM 6 min read Johnson Johnson s JNJ fourth-quarter 2020 earnings came in at 186 per share which beat the Zacks Consensus Estimate of 181. JJ JNJ beats fourth-quarter 2020 estimates for both earnings and sales.

Johnson Johnson JNJ reports earnings on 4272021. GAAP EPS of 133 misses by. Johnson Johnson NYSEJNJ announced its earnings results on Monday January 25th.

Shares of Johnson Johnson a major drug manufacturer climbed approximately 3 on Tuesday on the back of reporting fourth-quarter earnings results that topped analyst estimatesFor the quarter ended December 2020 the New Brunswick New Jersey-based company reported net income of 1738 billion or 65 cents in earnings per share compared with net income of 401 billion or 150 in. Johnson Johnson currently has an Earnings ESP of 719 which suggests that analysts have recently become bullish on the companys earnings prospects. Johnson Johnson on Tuesday reported fourth-quarter earnings and revenue that beat Wall Streets expectationsThe company also said it would release key details on its coronavirus vaccine soon.

Johnson Johnson NYSEJNJ last issued its quarterly earnings data on Monday January 25th. JJ JNJ Beats on Q3 Earnings Sales Ups 2020 Guidance Johnson Johnsons JNJ third-quarter 2020 earnings came in at 220 per share which beat the Zacks Consensus Estimate of 199. 13 2020 641 AM ET Johnson Johnson JNJ By.

It issues its adjusted earnings and sales outlook for 2021. Adjusted earnings are expected to come in at 940-960 per share rising 171. Early Tuesday Johnson Johnson JNJ beat third-quarter earnings estimates and raised full-year guidance after the Dow Jones giant late Monday said it paused its final-phase Covid-19 vaccine.

Oct 13 2020 Johnson Johnson JNJ - Get Report on Tuesday reported better-than-expected third-quarter earnings as demand for its drugs as well consumer products and equipment increased. The company reported 186 earnings per share EPS for the quarter beating the Zacks consensus estimate of 182 by 004. The company reported 186 earnings per share for the quarter beating the Thomson Reuters.

The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. This positive Earnings ESP when combined. Q3 Non-GAAP EPS of 220 beats by 022.

Mamta Mayani SA News Editor 32 Comments Johnson Johnson NYSE. For the year ending in 2021 Johnson Johnson expects 905 billion to 917 billion in sales growing 95-11.

Why Lowe S Low Is Poised To Beat Earnings Estimates Again